Upcoming Financial Results Conference Call of Beyond Air
Beyond Air, Inc. (NASDAQ: XAIR), known for its innovative medical devices and biopharmaceuticals, has announced the schedule for its first fiscal quarter financial results conference call. The call is set to take place soon after the company concludes its quarterly financial reporting for the quarter ending June 30, 2025.
Details of the Conference Call
The management of Beyond Air will be available to discuss the results via conference call on a specified Tuesday afternoon. The call is expected to begin at 4:30 PM Eastern Time. Participants can join the call using the following numbers:
- Domestic Call: 1-877-407-0784
- International Call: 1-201-689-8560
For those looking to join online, the company will provide a live webcast. This will allow participants who cannot join the call to follow insights directly from the leadership team. Recording of the call will also be accessible on their website shortly after its conclusion.
The Mission of Beyond Air
Beyond Air is passionately working on harnessing nitric oxide (NO) to enhance healthcare, particularly for patients facing serious health challenges such as respiratory issues and various cancers. The company's commitment to innovation has led to the development of its flagship product, LungFit® PH, which has received regulatory approvals to treat newborns with hypoxic respiratory failure.
Advancing Medical Solutions
Beyond Air has its sights set on multiple areas of improvement within respiratory and neurological health. Their clinical trials are underway for other versions of LungFit, targeting critical conditions such as severe lung infections and progressive diseases.
Collaborations and Future Goals
The company has also partnered with prominent institutions such as The Hebrew University of Jerusalem to explore innovative treatment pathways for autism spectrum disorder (ASD) and other neurological conditions. Through focused research, the company aims to expand its impact, moving from pre-clinical programs to effective patient solutions.
Community Impact and Innovations
Beyond Air is not just about treatment; it's about creating a healthier future. Their research into ultra-high concentrations of NO signifies an ambitious stride towards effectively addressing solid tumors. This initiative, within the pre-clinical phase, shows promise and underscores the company’s adaptability and responsiveness to medical needs.
Staying Connected
To keep stakeholders informed, Beyond Air encourages individuals to regularly check their website for news updates, financial reports, and event schedules, including the upcoming conference call. Interested parties are urged to stay engaged and follow the company’s progress as they delve deeper into innovative solutions.
Frequently Asked Questions
What is the purpose of Beyond Air's upcoming conference call?
The call is designed to share financial results for the first fiscal quarter and discuss insights from the management team.
How can one participate in the conference call?
Participants can dial in using specified domestic or international conference call numbers provided prior to the event.
What innovations is Beyond Air focusing on?
Beyond Air is concentrating on nitric oxide therapies to address respiratory diseases and neurological disorders while working on other impactful projects.
What is LungFit® PH?
LungFit® PH is Beyond Air's premier system approved for treating neonates with respiratory failure, marking a significant achievement for the company.
Who can be contacted for more information?
For inquiries, Corey Davis, Ph.D., from LifeSci Advisors is available for contact via email or phone.
